TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$50 Million

InVivo Therapeutics Holdings Corp

At-the-market Offering

InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.